SMARCA4 and non-small cell lung carcinoma: Other studies have reported the frequency of SMARCA4-inactivating mutations in non-small cell lung cancer (NSCLC) cell lines ranging from 15% to 35% (refs 8, 9), 5–10% in lung adenocarcinomas10, 11, 12 and 6% in lung squamous cell carcinomas13.